tnMainLogo.jpg
 

Advanced Therapeutic Antibody Discovery with Multiplexed Screening [Whitepaper]


Intellicyt1

IntelliCyt_logo

Antibody-based therapeutics are the fastest growing and most successful therapeutic modality for treating numerous diseases including cancer, autoimmune disorders and infectious disease.

Multiplexed high throughput screening has become an essential component in the discovery of therapeutic antibodies.

Download this whitepaper to learn:

• How to perform multiplexed screens for antibody binding to either cell surface or to circulating target antigens.
• How the Intellicyt® iQue Screener PLUS platform can be used to carry out high content assays to evaluate the effects of lead candidates in multiplexed cell based and secreted protein assays.